An additional indicative point is sequential involvement
Important Safety Information for SOLIQUA 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 33 mcg/mL What is the most important information I should know about SOLIQUA 100/33
While our findings regarding serum HDL-c levels contradicted those of Wang et al .[62], who reported no statistical significance, although its essential to note that their focus was primarily on breast cancer, which differs from our studys scope [62].Moreover, our study did not find statistical significance in cholesterol and triglyceride levels, aligning with findings from other studies suggesting that these parameters may not be directly associated with disease initiation or progression from radiation exposure [63, 64, 65]
Learn more about Oligopeptide-1 This ingredient is a high-molecular weight synthetic polymer
Common side effects include nausea and vomiting (slightly more common with the pill version), diarrhoea and/or constipation and abdominal discomfort, but these generally settle once people get used to the medicine
Preclinical data is based on animal models